Early stimulation treatment provides complete sensory-induced protection from ischemic stroke under isoflurane anesthesia

Authors

  • Christopher C. Lay,

    1. Department of Neurobiology and Behavior, University of California, Irvine, CA, USA
    2. The Center for the Neurobiology of Learning and Memory, University of California, Irvine, CA, USA
    3. The Center for Hearing Research, University of California, Irvine, CA, USA
    Search for more papers by this author
  • Nathan Jacobs,

    1. Department of Neurobiology and Behavior, University of California, Irvine, CA, USA
    2. The Center for the Neurobiology of Learning and Memory, University of California, Irvine, CA, USA
    Search for more papers by this author
  • Aneeka M. Hancock,

    1. Department of Neurobiology and Behavior, University of California, Irvine, CA, USA
    2. The Center for the Neurobiology of Learning and Memory, University of California, Irvine, CA, USA
    Search for more papers by this author
  • Yi Zhou,

    1. Department of Neurobiology and Behavior, University of California, Irvine, CA, USA
    2. The Center for the Neurobiology of Learning and Memory, University of California, Irvine, CA, USA
    Search for more papers by this author
  • Ron D. Frostig

    Corresponding author
    1. Department of Neurobiology and Behavior, University of California, Irvine, CA, USA
    2. Department of Biomedical Engineering, University of California, Irvine, CA, USA
    3. The Center for the Neurobiology of Learning and Memory, University of California, Irvine, CA, USA
    4. The Center for Hearing Research, University of California, Irvine, CA, USA
    • Correspondence: Dr Ron D. Frostig, 1Department of Neurobiology and Behavior, as above.

      E-mail: rfrostig@uci.edu

    Search for more papers by this author

Abstract

Using a rodent model of ischemia [permanent middle cerebral artery occlusion (pMCAO)], previous studies demonstrated that whisker stimulation treatment completely protects the cortex from impending stroke when initiated within 2 h following pMCAO. When initiated 3 h post-pMCAO, the identical treatment exacerbates stroke damage. Rats in these studies, however, were anesthetised with sodium pentobarbital, whereas human stroke patients are typically awake. To overcome this drawback, our laboratory has begun to use the anesthetic isoflurane, which allows rats to rapidly recover from pMCAO within minutes, to test stimulation treatment in awake rats and to determine whether isoflurane has an effect upon the pMCAO stroke model. We found no difference in infarct volume between pMCAO in untreated controls under either sodium pentobarbital or isoflurane, and the primary finding was that rats that received treatment immediately post-pMCAO maintain cortical function and no stroke damage, whereas rats that received treatment 3 h post-pMCAO exhibited eliminated cortical activity and extensive stroke damage. The only difference between anesthetics was the broad extent of evoked cortical activity observed during both functional imaging and electrophysiological recording, suggesting that the extent of evoked activity evident under isoflurane anesthesia is supported by underlying neuronal activity. Given the high degree of similarity with previous data, we conclude that the pMCAO stroke model is upheld with the use of isoflurane. This study demonstrated that the isoflurane-anesthetised rat pMCAO model can be used for cerebrovascular studies, and allows for highly detailed investigation of potential novel treatments for ischemic stroke using awake, behaving animals.

Ancillary